• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Smart Review Process for Medical Device Registration Coming Soon?

Smart Review Process for Medical Device Registration Coming Soon?

Friday, 22 January 2021 / Published in Medical Device, NMPA Registration in China

Smart Review Process for Medical Device Registration Coming Soon?

The Center for Medical Device Evaluation (CDME) of National Medical Products Administration (NMPA) has recognized the positive performance of the fast-track approval process for the registration of medical devices in 2020. Prior to Coronavirus the pathway was seldom used, but 2020 saw higher volumes and its success has encouraged the CDME to implement a smart review process to further streamline and objectivize the registration process.

On December 18, 2020, the CMDE published a short review about the control work deployed to combat the coronavirus outbreak and reported a total of 76 medical devices that were urgently approved to enter the China market. The CMDE confirmed that the fast-track approval process was the key to help control the pandemic situation.

Considering the events and regulatory decisions made in 2020, the CDME announced their plan to establish a smart review process for the registration of medical devices in China, in order to enable automated task distribution and eliminate the possibilities of personal influence or conflict of interest upon the official decision of granting approvals.

Stay tuned for more details about the implementation of the smart review process in China.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: COVID-19, fast-track approval, Smart Review Process

What you can read next

New Details on Sampling Inspections of Medical Devices
nmpa clinical trial pathway
NMPA clinical trial pathway has been updated for 15 medical device categories
china-vaccine-production
China vaccine production and distribution rules released

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.